UKCA & MHRA Medical Device Regulatory Support

UKCA and MHRA regulatory support for medical devices including transition from CE marking.

UKCA & MHRA Regulatory Support

We support manufacturers navigating UKCA marking and MHRA requirements, including CE to UKCA transition strategies.

Our approach integrates technical documentation alignment, classification strategy, and lifecycle regulatory management — ensuring structured compliance under the UK Medical Devices Regulations 2002 (as amended).

SEND YOUR ENQUIRY

UKCA & MHRA Registration

Bioexcel supports manufacturers navigating the UK regulatory framework, including UKCA marking, CE transition strategy, and MHRA registration requirements.
UKCA & MHRA Registration

UKCA marking roadmap

MHRA device registration (DORS)

UK Responsible Person documentation

Declaration of Conformity alignment

Labeling & UDI compliance (UK requirements)

Regulatory Framework Alignment

Our UK submissions align with:

UK Medical Devices Regulations 2002 (as amended)

MHRA guidance documents

UKCA conformity assessment requirements

UK vigilance reporting obligations

PMS & post-market monitoring expectations

We structure documentation anticipating MHRA review expectations and market surveillance scrutiny.

Beyond UK Registration Support

We design UK regulatory strategies with:

Structured CE-to-UKCA transition architecture

Clear documentation defensibility

UKRP integration planning

Regulatory continuity risk mitigation

Harmonized EU–UK lifecycle compliance

Our objective: ensure seamless UK market access without regulatory disruption.

Capabilities

Capabilities – UK device classification – UKCA transition planning – Technical documentation alignment – MHRA registration support

Regulatory Pathway & Classification

UK device classification (Class I, IIa, IIb, III)
IVD classification alignment
CE to UKCA transition planning
UK Responsible Person (UKRP) strategy
Conformity assessment route determination

Discuss UKCA Compliance

UKCA & MHRA Regulatory Support_page-0002

Technical Documentation Alignment

Technical file & design dossier review
Clinical evaluation alignment (UK expectations)
PMS & Vigilance framework alignment
Risk management documentation (ISO 14971)
Post-market surveillance & UK vigilance reporting strategy

Lifecycle Compliance & Transition Strategy

CE to UKCA migration roadmap
Regulatory change management
Post-approval variation support
Vigilance reporting architecture
Ongoing compliance monitoring

Frequently Asked Questions (FAQ)

Can the same clinical evidence be used across regions?Bioexcelife2026-02-10T09:24:10+00:00

Can the same clinical evidence be used across regions?

Often yes, with region-specific adaptations based on regulatory requirements.

Does Bioexcel guarantee regulatory approval?Bioexcelife2026-02-10T09:22:59+00:00

Does Bioexcel guarantee regulatory approval?

No. Bioexcel supports compliant preparation and strategy; final approval decisions rest with regulatory
authorities.